BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26204831)

  • 1. Baicalin Protects Mice from Aristolochic Acid I-Induced Kidney Injury by Induction of CYP1A through the Aromatic Hydrocarbon Receptor.
    Wang K; Feng C; Li C; Yao J; Xie X; Gong L; Luan Y; Xing G; Zhu X; Qi X; Ren J
    Int J Mol Sci; 2015 Jul; 16(7):16454-68. PubMed ID: 26204831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tanshinone I protects mice from aristolochic acid I-induced kidney injury by induction of CYP1A.
    Feng C; Xie X; Wu M; Li C; Gao M; Liu M; Qi X; Ren J
    Environ Toxicol Pharmacol; 2013 Nov; 36(3):850-7. PubMed ID: 23981375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAD(P)H:quinone oxidoreductase expression in Cyp1a-knockout and CYP1A-humanized mouse lines and its effect on bioactivation of the carcinogen aristolochic acid I.
    Levova K; Moserova M; Nebert DW; Phillips DH; Frei E; Schmeiser HH; Arlt VM; Stiborova M
    Toxicol Appl Pharmacol; 2012 Dec; 265(3):360-7. PubMed ID: 22982977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of P450 1A1 and P450 1A2 in bioactivation versus detoxication of the renal carcinogen aristolochic acid I: studies in Cyp1a1-/-, Cyp1a2-/-, and Cyp1a1/1a2-/- mice.
    Arlt VM; Levová K; Bárta F; Shi Z; Evans JD; Frei E; Schmeiser HH; Nebert DW; Phillips DH; Stiborová M
    Chem Res Toxicol; 2011 Oct; 24(10):1710-9. PubMed ID: 21932800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions and difficult answers.
    Stiborova M; Frei E; Arlt VM; Schmeiser HH
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):5-11. PubMed ID: 19365519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Naphthoflavone protects mice from aristolochic acid-I-induced acute kidney injury in a CYP1A dependent mechanism.
    Xiao Y; Xue X; Wu YF; Xin GZ; Qian Y; Xie TP; Gong LK; Ren J
    Acta Pharmacol Sin; 2009 Nov; 30(11):1559-65. PubMed ID: 19890363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of P450 1A by 3-methylcholanthrene protects mice from aristolochic acid-I-induced acute renal injury.
    Xue X; Xiao Y; Zhu H; Wang H; Liu Y; Xie T; Ren J
    Nephrol Dial Transplant; 2008 Oct; 23(10):3074-81. PubMed ID: 18495746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cytochromes P450 in metabolism of carcinogenic aristolochic acid I: evidence of their contribution to aristolochic acid I detoxication and activation in rat liver.
    Stiborova M; Mares J; Levova K; Pavlickova J; Barta F; Hodek P; Frei E; Schmeiser HH
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():121-30. PubMed ID: 22167220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cytochromes P450 1A1/2 in detoxication and activation of carcinogenic aristolochic acid I: studies with the hepatic NADPH:cytochrome P450 reductase null (HRN) mouse model.
    Levová K; Moserová M; Kotrbová V; Sulc M; Henderson CJ; Wolf CR; Phillips DH; Frei E; Schmeiser HH; Mares J; Arlt VM; Stiborová M
    Toxicol Sci; 2011 May; 121(1):43-56. PubMed ID: 21362632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactivation versus detoxication of the urothelial carcinogen aristolochic acid I by human cytochrome P450 1A1 and 1A2.
    Stiborová M; Levová K; Bárta F; Shi Z; Frei E; Schmeiser HH; Nebert DW; Phillips DH; Arlt VM
    Toxicol Sci; 2012 Feb; 125(2):345-58. PubMed ID: 22086975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical investigation of differences in nitroreduction of aristolochic acid I by cytochromes P450 1A1, 1A2 and 1B1.
    Jerabek P; Martinek V; Stiborova M
    Neuro Endocrinol Lett; 2012; 33 Suppl 3():25-32. PubMed ID: 23353840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice.
    Arlt VM; Zuo J; Trenz K; Roufosse CA; Lord GM; Nortier JL; Schmeiser HH; Hollstein M; Phillips DH
    Int J Cancer; 2011 Jan; 128(1):21-32. PubMed ID: 20232387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of organic anion transporters 1 and 3 in kidney accumulation and toxicity of aristolochic acid I.
    Xue X; Gong LK; Maeda K; Luan Y; Qi XM; Sugiyama Y; Ren J
    Mol Pharm; 2011 Dec; 8(6):2183-92. PubMed ID: 21980933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockout and humanized mice as suitable tools to identify enzymes metabolizing the human carcinogen aristolochic acid.
    Stiborová M; Frei E; Arlt VM; Schmeiser HH
    Xenobiotica; 2014 Jan; 44(2):135-45. PubMed ID: 24152141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway.
    Wu J; Liu X; Fan J; Chen W; Wang J; Zeng Y; Feng X; Yu X; Yang X
    Toxicology; 2014 Apr; 318():22-31. PubMed ID: 24530882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of p53 on aristolochic acid I-induced nephrotoxicity and DNA damage in vivo and in vitro.
    Sborchia M; De Prez EG; Antoine MH; Bienfait L; Indra R; Valbuena G; Phillips DH; Nortier JL; Stiborová M; Keun HC; Arlt VM
    Arch Toxicol; 2019 Nov; 93(11):3345-3366. PubMed ID: 31602497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of genetic modulation of SULT1A enzymes on DNA adduct formation by aristolochic acids and 3-nitrobenzanthrone.
    Arlt VM; Meinl W; Florian S; Nagy E; Barta F; Thomann M; Mrizova I; Krais AM; Liu M; Richards M; Mirza A; Kopka K; Phillips DH; Glatt H; Stiborova M; Schmeiser HH
    Arch Toxicol; 2017 Apr; 91(4):1957-1975. PubMed ID: 27557898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats.
    Bárta F; Dedíková A; Bebová M; Dušková Š; Mráz J; Schmeiser HH; Arlt VM; Hodek P; Stiborová M
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 1A2 detoxicates aristolochic acid in the mouse.
    Rosenquist TA; Einolf HJ; Dickman KG; Wang L; Smith A; Grollman AP
    Drug Metab Dispos; 2010 May; 38(5):761-8. PubMed ID: 20164109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal chymase-dependent pathway for angiotensin II formation mediated acute kidney injury in a mouse model of aristolochic acid I-induced acute nephropathy.
    Hsieh WY; Chang TH; Chang HF; Chuang WH; Lu LC; Yang CW; Lin CS; Chang CC
    PLoS One; 2019; 14(1):e0210656. PubMed ID: 30633770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.